Andreas Reinisch
Affiliations: | 2012-2017 | University of Graz |
Google:
"Andreas Reinisch"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fan AC, Nakauchi Y, Bai L, et al. (2023) RUNX1 loss renders hematopoietic and leukemic cells dependent on interleukin-3 and sensitive to JAK inhibition. The Journal of Clinical Investigation |
| Sconocchia T, Foßelteder J, Köhnke T, et al. (2023) Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments : Jove |
| Foßelteder J, Pabst G, Sconocchia T, et al. (2023) Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia |
| Thompson-Peach CAL, Foßelteder J, Reinisch A, et al. (2023) Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms. Bio-Protocol. 13: e4592 |
| Thomas D, Wu M, Nakauchi Y, et al. (2022) Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer Discovery |
| Nakauchi Y, Azizi A, Thomas D, et al. (2022) The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia. Blood Cancer Discovery |
| Tvorogov D, Thompson-Peach CAL, Foßelteder J, et al. (2022) Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody. Embo Reports. e52904 |
| Jensen TI, Mikkelsen NS, Gao Z, et al. (2021) Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome Research |
| Mantri S, Reinisch A, Dejene BT, et al. (2020) CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products. Blood Advances. 4: 5357-5361 |
| Daga S, Rosenberger A, Kashofer K, et al. (2020) Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling. American Journal of Hematology |